Melanoma Institute Australia Fellowship Program
MIA offers a number of unique clinical and research-based Fellowships each year to train and educate the melanoma clinicians of the future. These Fellowships offer an outstanding opportunity for high-level training in medical oncology, melanoma surgical oncology, melanoma pathology, and dermatology.
Melanoma Institute Australia Immuno-Oncology/Clinical Trials Fellowship
Melanoma Institute Australia (MIA) has two full-time Fellowship positions for medical oncology trainees, RACP Fellows or overseas equivalents. These Fellowships will start in February 2023 and be for one year in duration.
These positions will provide a unique opportunity for the right individuals to obtain training in clinical trials, clinical research and immunotherapy treatment for melanoma and complex skin cancer patients in a multi-disciplinary, clinical and translational research environment.
Highlights of the role include:
- Ample opportunity to participate in world-leading clinical research
- Joining a world class organisation in the provision of melanoma and complex skin cancer care, research and education
- Specialising in immuno-oncology through an unparalleled experience in treatment, clinical trials and research
- Becoming an integral member of a coordinated, supportive and enthusiastic clinical trials team, managing patients on Ph I, II and III clinical trials, treated with novel immune and targeted therapies
- Working in a dynamic environment in a recognised centre of excellence
MIA is an independent, not-for-profit research institute located in North Sydney (NSW, Australia). The Institute is affiliated with the University of Sydney and collaborates with clinicians at various hospitals in Sydney. Our dynamic and high-volume multidisciplinary team sees approximately 500 new patients each year and lead a large number of clinical trials of novel agents, including investigator-initiated clinical and translational studies. The Institute has become a major referral center in Australia, and the care and research conducted by the Institute is widely regarded as world-class.
These positions will involve participation in outpatient multidisciplinary melanoma care and complex skin cancer, strong involvement in the conduct and medical oversight of medical oncology clinical trials, and the conduct of clinical research programs. Fellows have time and opportunity to participate in the academic activities of the Institute, including leading research projects for presentation at a major international conferences and publication in high-ranking journals. Opportunity for part-time postgraduate study is available, as is the potential to transfer after completion of the fellowship into a full-time PhD.
Applicants need to have recent experience working in Medical Oncology (or Dermato-oncology for German/Swiss candidates) in a formal training program or have completed training. Appropriate regulatory assistance will be given to facilitate the best overall candidates. Base salary of AUD $125,000 p.a.
To apply for this position, please contact Kylie Scott, Head of Human Resources, Melanoma Institute Australia.
A candidate application form will be forwarded onto you for completion and to submit as your formal interest in the position.
Email: firstname.lastname@example.org. Telephone: (02) 9911 7237.
Applications close Friday 29 October 2021.
Poche Fellow in Melanoma and Surgical Oncology
Applications are invited from qualified General or Plastic Surgeons for the Poche Fellowship in Melanoma and Surgical Oncology.
This program is based at the Melanoma Institute Australia’s North Sydney campus, as well as the Mater Hospital Crows Nest, and Royal Prince Alfred Hospital Camperdown.
This position is formatted at a post Fellowship level (FRACS or equivalent) and is suitable for surgeons seeking to develop a vocational interest in the field.
Each year we offer two clinical and research-based Fellowships, which are for twelve months commencing in February 2023. The Fellowships involve a substantial clinical workload in dedicated outpatient clinics, operating sessions and weekly multidisciplinary meetings.
The Melanoma Institute Australia is one of the world’s largest melanoma services, and access to its internationally respected Melanoma Research Database provides the opportunity to undertake significant research during this Fellowship.
Applications are accepted from Australian and non-Australian candidates.
Fellowships are available from February/March 2023 to February/March 2024. Applications will close 29 October 2021.
Interested candidates should submit the following:
- curriculum vitae
- cover letter highlighting why you want to become a MIA Melanoma Surgery Fellow
- proof of specialist qualification
- current medical registration/licensing
- medical indemnity
- contact details of three referees
Please address your application to:
A/Prof Robyn Saw, Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, 2060, Australia
We pay our respects to the Traditional Custodians of the lands on which Melanoma Institute Australia works, and their elders both past and present, and acknowledge the deep, continuing connection of Aboriginal and Torres Straight Islander peoples to the land, waters and sky.
Melanoma Institute Australia (MIA) and Royal Prince Alfred Hospital (RPAH) offer one year Fellowships, involving work at RPAH, MIA Poche Centre and The University of Sydney.
The Fellowship is suitable for qualified pathologists/final year anatomical pathology trainees. The position will provide a unique opportunity for the right individual to:
- enhance their clinical diagnostic skills in pigmented lesion pathology and dermatopathology,
- obtain additional experience/training in surgical/molecular pathology and research,
- gain experience in interpretation of difficult consultation cases (>2500 annually)
- participate in the MIA translational melanoma research program
- enhance their knowledge of the treatment and care of melanoma patients.
MIA is a world leader in melanoma research, clinical care and education. It is an independent, non- profit organisation that is formally affiliated with the University of Sydney and the RPAH. The Institute is staffed by an internationally recognised multidisciplinary team of senior clinicians and researchers. The award winning MIA translational research program is supported by research funding from the National Health and Medical Research Council of Australia and Cancer Institute New South Wales. The MIA Biospecimen Bank contains the largest number of annotated melanoma specimens worldwide. The Institute is a leading site for melanoma clinical trials.
Pathology is a critical aspect of the multidisciplinary care of melanoma patients at MIA. All patients who are referred for care at MIA routinely have their pathology reviewed by MIA pathologists (over 1500 new melanoma cases each year). The tissue pathology service for MIA is provided by the Department of Tissue Pathology and Diagnostic Oncology at the RPAH, Sydney where there is a dedicated team of pathologists with special expertise in the diagnosis of pigmented lesions (including Professor Richard Scolyer, Dr Robert Rawson, Dr Peter Ferguson and Dr Andrew Colebatch). In addition, Prof Scolyer receives a large number of consultation cases from other pathologists both nationally and internationally. These unique resources offer unparalleled opportunities to both gain clinical experience in dermatopathology and to perform translation clinical and translational research.
Positions are based in the Department of Tissue Pathology and Diagnostic Oncology at the RPAH and enables the successful applicant to work within a dynamic and high volume department. The department is an academic Pathology Department in a large tertiary referral hospital and is responsible for providing a high quality diagnostic service in all areas of Anatomical Pathology including surgical pathology, molecular pathology, electron microscopy and cytopathology. It services all subspecialities and receives a large number of consultation cases.
Fellows are expected to participate in the academic activities of the Institute. It is envisaged that the Fellows position would involve 50% clinical pathology and 50% research. They would be invited to participate in the routine reporting of the department to gain further clinical experience, if desired, at a level commensurate with their experience/qualifications.
The role would encompass the following core areas:
- Obtain training and education in the pathological diagnosis and reporting of melanocytic pathology, dermatopathology and other pathology
- Develop an understanding of pathology reporting standards
- Participate in the MIA research program on molecular determinants of risk, progression and treatment response in melanoma and other pathology research projects including the melanoma genome project.
- Participate in the MIA and RPAH training and education activities
- Present at the weekly melanoma multidisciplinary team meeting
- Gain further expertise in other areas of diagnostic and molecular pathology at a major tertiary referral centre
Interested fellows should be a Fellow of the Royal College of Pathologists of Australasia, or equivalent, or be in their final year of training. They must also be eligible for registration with the Medical Board of Australia.
Should you wish to express your interest in a fellowship please submit your resume and cover letter to email@example.com
Melanoma Institute Australia Dermatology Fellowship - Pigmented lesions and advanced imaging
Melanoma Institute Australia would like to invite applications for a full-time Fellowship position in Dermatology.
Fellowships commence in February each year and are for one year in duration. The position provides a unique opportunity for the right individual to obtain training in the diagnosis and treatment of challenging pigmented lesions and melanoma, as well as cutaneous immune-oncology in a multi - disciplinary, clinical and translational research environment. MIA is an independent, non-profit organisation located in North Sydney (NSW, Australia). The Institute is formally affiliated with the University of Sydney.
• Join a world class organisation in the provision of melanoma care, research and education
• Opportunity to participate in world-leading clinical research
• A dynamic environment in a recognised centre of excellence
The position involves:
- Training in advanced non-invasive imaging techniques for pigmented lesions, including confocal microscopy, optical coherence tomography, advanced dermoscopy, 3D total body photography.
- Co-ordination of high-risk clinics for patients at high and extreme-high risk of primary cutaneous melanoma
- Participation in outpatient multidisciplinary melanoma care
- Clinico-pathological correlation
- Strong involvement in clinical research programs
Fellows are required to participate in the academic activities of the Institute, including conducting research projects for presentation at a major international conferences and publication in high-ranking journals. Opportunity for part-time postgraduate study for a Masters, as is the potential to transfer after completion of the fellowship into a full-time PhD at the University of Sydney.
Essential criteria include:
- Hold fellowship of the Australian College of Dermatologists (FACD) of equivalent
- Be eligible for registration with the Medical Board of Australia (AHPRA)
Priority is given to Australian candidates. Appropriate regulatory assistance will be given to facilitate the best overall candidates. Further Information can be found at www.melanoma.org.au and www.melanomadermatology.com.au
Interested candidates should submit the following:
• curriculum vitae
• cover letter highlighting why you want to become an MIA Melanoma Fellow
• proof of specialist qualification
• current medical registration/licensing
• medical indemnity
• contact details of three referees
To apply for this position, please contact Kylie Scott, Head of Human Resources, Melanoma Institute Australia. Email: firstname.lastname@example.org